202 related articles for article (PubMed ID: 36587202)
1. High-density lipoprotein subclasses and cardiovascular disease and mortality in type 2 diabetes: analysis from the Hong Kong Diabetes Biobank.
Jin Q; Lau ESH; Luk AO; Tam CHT; Ozaki R; Lim CKP; Wu H; Chow EYK; Kong APS; Lee HM; Fan B; Ng ACW; Jiang G; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JY; Tsang MW; Cheung EYN; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Yu W; Tsui SKW; Huang Y; Lan HY; Szeto CC; So WY; Jenkins AJ; Chan JCN; Ma RCW;
Cardiovasc Diabetol; 2022 Dec; 21(1):293. PubMed ID: 36587202
[TBL] [Abstract][Full Text] [Related]
2. Associations of lipoprotein subclasses with risk of all-cause and cardiovascular disease mortality in individuals with type 2 diabetes: A prospective cohort study.
Li R; Chen JX; Lu Q; Geng TT; Xia PF; Wang Y; Chen LK; Shan ZL; Pan A; Liu G
Diabetes Obes Metab; 2023 Nov; 25(11):3259-3267. PubMed ID: 37492984
[TBL] [Abstract][Full Text] [Related]
3. Skin autofluorescence is associated with higher risk of cardiovascular events in Chinese adults with type 2 diabetes: A prospective cohort study from the Hong Kong Diabetes Biobank.
Jin Q; Lau ESH; Luk AOY; Ozaki R; Chow EYK; Cheng F; So T; Yeung T; Loo KM; Lim CKP; Kong APS; Jenkins AJ; Chan JCN; Ma RCW;
J Diabetes Complications; 2021 Oct; 35(10):108015. PubMed ID: 34384706
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of circulating NMR metabolic biomarkers for type 2 diabetes risk in the UK Biobank study.
Bragg F; Trichia E; Aguilar-Ramirez D; Bešević J; Lewington S; Emberson J
BMC Med; 2022 May; 20(1):159. PubMed ID: 35501852
[TBL] [Abstract][Full Text] [Related]
5. Circulating metabolomic markers linking diabetic kidney disease and incident cardiovascular disease in type 2 diabetes: analyses from the Hong Kong Diabetes Biobank.
Jin Q; Lau ESH; Luk AO; Tam CHT; Ozaki R; Lim CKP; Wu H; Chow EYK; Kong APS; Lee HM; Fan B; Ng ACW; Jiang G; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JY; Tsang MW; Cheung EYN; Kam G; Lau IT; Li JK; Yeung VTF; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Yu W; Tsui SKW; Tomlinson B; Huang Y; Lan HY; Szeto CC; So WY; Jenkins AJ; Fung E; Muilwijk M; Blom MT; 't Hart LM; Chan JCN; Ma RCW;
Diabetologia; 2024 May; 67(5):837-849. PubMed ID: 38413437
[TBL] [Abstract][Full Text] [Related]
6. High-density lipoprotein subclass measurements improve mortality risk prediction, discrimination and reclassification in a cardiac catheterization cohort.
McGarrah RW; Craig DM; Haynes C; Dowdy ZE; Shah SH; Kraus WE
Atherosclerosis; 2016 Mar; 246():229-35. PubMed ID: 26803432
[TBL] [Abstract][Full Text] [Related]
7. Relations of GlycA and lipoprotein particle subspecies with cardiovascular events and mortality: A post hoc analysis of the AIM-HIGH trial.
Otvos JD; Guyton JR; Connelly MA; Akapame S; Bittner V; Kopecky SL; Lacy M; Marcovina SM; Muhlestein JB; Boden WE
J Clin Lipidol; 2018; 12(2):348-355.e2. PubMed ID: 29409728
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease.
Welsh C; Celis-Morales CA; Brown R; Mackay DF; Lewsey J; Mark PB; Gray SR; Ferguson LD; Anderson JJ; Lyall DM; Cleland JG; Jhund PS; Gill JMR; Pell JP; Sattar N; Welsh P
Circulation; 2019 Aug; 140(7):542-552. PubMed ID: 31216866
[TBL] [Abstract][Full Text] [Related]
9. Both LDL and HDL particle concentrations associate positively with an increased risk of developing microvascular complications in patients with type 2 diabetes: lost protection by HDL (Zodiac-63).
Bourgonje AR; Connelly MA; van Goor H; van Dijk PR; Dullaart RPF
Cardiovasc Diabetol; 2023 Jul; 22(1):169. PubMed ID: 37415152
[TBL] [Abstract][Full Text] [Related]
10. Obesity, clinical, and genetic predictors for glycemic progression in Chinese patients with type 2 diabetes: A cohort study using the Hong Kong Diabetes Register and Hong Kong Diabetes Biobank.
Jiang G; Luk AO; Tam CHT; Lau ES; Ozaki R; Chow EYK; Kong APS; Lim CKP; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JYY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung SKS; Cheng YL; Chow CC; Pearson ER; So WY; Chan JCN; Ma RCW; ;
PLoS Med; 2020 Jul; 17(7):e1003209. PubMed ID: 32722720
[TBL] [Abstract][Full Text] [Related]
11. Diabetes with poor-control HbA1c is cardiovascular disease 'risk equivalent' for mortality: UK Biobank and Hong Kong population-based cohort study.
Wan EYF; Yu EYT; Mak IL; Youn HM; Chan KS; Chan EWY; Wong ICK; Lam CLK
BMJ Open Diabetes Res Care; 2023 Jan; 11(1):. PubMed ID: 36634978
[TBL] [Abstract][Full Text] [Related]
12. Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus : Secondary Analysis of a Randomized Clinical Trial.
Dugani SB; Akinkuolie AO; Paynter N; Glynn RJ; Ridker PM; Mora S
JAMA Cardiol; 2016 May; 1(2):136-45. PubMed ID: 27347563
[TBL] [Abstract][Full Text] [Related]
13. Predictive Value of the Triglyceride to High-Density Lipoprotein Cholesterol Ratio for All-Cause Mortality and Cardiovascular Death in Diabetic Patients With Coronary Artery Disease Treated With Statins.
Wang L; Cong H; Zhang J; Hu Y; Wei A; Zhang Y; Yang H; Ren L; Qi W; Li W
Front Cardiovasc Med; 2021; 8():718604. PubMed ID: 34368266
[No Abstract] [Full Text] [Related]
14. Novel Size-Based High-Density Lipoprotein Subspecies and Incident Vascular Events.
Deets A; Joshi PH; Chandra A; Singh K; Khera A; Virani SS; Ballantyne CM; Otvos JD; Dullaart RPF; Gruppen EG; Connelly MA; Ayers C; Navar AM; Pandey A; Wilkins JT; Rohatgi A
J Am Heart Assoc; 2023 Nov; 12(21):e031160. PubMed ID: 37929707
[TBL] [Abstract][Full Text] [Related]
15. The predictive study of the relation between elevated low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and mortality in peritoneal dialysis.
Lin T; Xia X; Yu J; Qiu Y; Yi C; Lin J; Mao H; Yang X; Huang F
Lipids Health Dis; 2020 Mar; 19(1):51. PubMed ID: 32199459
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin).
Khera AV; Demler OV; Adelman SJ; Collins HL; Glynn RJ; Ridker PM; Rader DJ; Mora S
Circulation; 2017 Jun; 135(25):2494-2504. PubMed ID: 28450350
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein Particle Profiles, Standard Lipids, and Peripheral Artery Disease Incidence.
Aday AW; Lawler PR; Cook NR; Ridker PM; Mora S; Pradhan AD
Circulation; 2018 Nov; 138(21):2330-2341. PubMed ID: 30021845
[TBL] [Abstract][Full Text] [Related]
18. Alcohol Consumption, High-Density Lipoprotein Particles and Subspecies, and Risk of Cardiovascular Disease: Findings from the PREVEND Prospective Study.
Kunutsor SK; Bhattacharjee A; Connelly MA; Bakker SJL; Dullaart RPF
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396968
[TBL] [Abstract][Full Text] [Related]
19. High-Density Lipoprotein Subclasses and Noncardiovascular, Noncancer Chronic Inflammatory-Related Events Versus Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis.
Duprez DA; Otvos J; Tracy RP; Feingold KR; Greenland P; Gross MD; Lima JA; Mackey RH; Neaton JD; Sanchez OA; Jacobs DR
J Am Heart Assoc; 2015 Sep; 4(9):e002295. PubMed ID: 26370448
[TBL] [Abstract][Full Text] [Related]
20. Associations of comorbid depression with cardiovascular-renal events and all-cause mortality accounting for patient reported outcomes in individuals with type 2 diabetes: a 6-year prospective analysis of the Hong Kong Diabetes Register.
Yeung YL; Lee KL; Lau ES; Yung TF; Yang A; Wu H; Wong KT; Kong AP; Chow EY; Ma RC; Yeung T; Loo KM; Ozaki R; Luk AO; Lui JN; Chan JC
Front Endocrinol (Lausanne); 2024; 15():1284799. PubMed ID: 38586459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
